[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@biospace](/creator/twitter/biospace) "Despite the rejection analysts saw Regenerons use of an alternate filler for Eylea HD as a positive development with BMO Capital Markets noting that this could signal the end of manufacturing troubles for the franchise. #FDA #manufacturing #pharma #biospace" [X Link](https://x.com/biospace/status/1983556932615967222) [@biospace](/creator/x/biospace) 2025-10-29T15:30Z 25.4K followers, XXX engagements "Pfizer Merck AstraZeneca and Bristol Myers Squibb were among the many biopharmas showing off novel cancer modalities at ESMO with antibody-drug conjugates bispecific antibodies and kinase inhibitors demonstrating encouraging efficacy and safety for various cancers. #ADC #biopharma #biospace" [X Link](https://x.com/biospace/status/1981060231372185651) [@biospace](/creator/x/biospace) 2025-10-22T18:09Z 25.4K followers, XXX engagements "From a small team of researchers and skipped salaries CEO Michelle Xia has steered Akeso to become one of the most exciting companies in the industry today. #biotech #biospace" [X Link](https://x.com/biospace/status/1968321541638131890) [@biospace](/creator/x/biospace) 2025-09-17T14:29Z 25.4K followers, XXX engagements "M&A headlined for a second straight week as Genmab acquired Merus for $X billion; Pfizer strikes most-favored-nation deal with White House; CDER Director George Tidmarsh caused a stir with a now-deleted LinkedIn post; GSK CEO Emma Walmsley will step down from her role; and uniQures gene therapy offers new hope for patients with Huntingtons disease. #podcast #CDER #rarediseases #mergers #biospace" [X Link](https://x.com/biospace/status/1973404158863544589) [@biospace](/creator/x/biospace) 2025-10-01T15:06Z 25.4K followers, XXX engagements "While the benefits of AI are clear the amount data sets needed for effective AI integration is proving to be a challenge. This is particularly true for cell therapy companies as they are eagerly seeking ways to reduce development costs. Two experts at Charles River Laboratories provide insights by giving their takeaways from their own AI integrations. #AI #CART #celltherapy #biospace" [X Link](https://x.com/biospace/status/1977737585607819743) [@biospace](/creator/x/biospace) 2025-10-13T14:05Z 25.4K followers, XXX engagements "Regeneron is aiming to file a regulatory application for DB-OTO by the end of the year. #genetherapy #regulatory #biospace" [X Link](https://x.com/biospace/status/1977798485085712562) [@biospace](/creator/x/biospace) 2025-10-13T18:07Z 25.4K followers, XXX engagements "Elecsys approval could help boost the uptake of currently approved Alzheimers disease therapies including Biogens Eisai-partnered Leqembi with CEO Chris Viehbacher recently noting that such biomarker-based tests could remove some of the bottlenecks in uptake. #alzheimers #FDA #biospace" [X Link](https://x.com/biospace/status/1978121114376126531) [@biospace](/creator/x/biospace) 2025-10-14T15:30Z 25.4K followers, XXX engagements "After the FDA revoked Sarepta Therapeutics platform designation in July Krystal Biotech is poised to be the first major beneficiary of this program according to analysts at William Blair. #FDA #genetherapy #biotech #biospace" [X Link](https://x.com/biospace/status/1978478489968721936) [@biospace](/creator/x/biospace) 2025-10-15T15:10Z 25.4K followers, XXX engagements "Due largely to @CSL @Merck and @novonordisks reorganizations that could total about 19350 people Q3 cuts rose significantly year over year and quarter over quarter based on BioSpace tallies. #layoffs #biopharma #biospace" [X Link](https://x.com/biospace/status/1978839595832787133) [@biospace](/creator/x/biospace) 2025-10-16T15:04Z 25.4K followers, XXX engagements "As part of its restructuring that includes cutting about 9000 employees globally @novonordisk is reportedly laying off U.S. employees this week and continuing into next week. Learn more in our layoff tracker. #layoffs #biopharma #biospace" [X Link](https://x.com/biospace/status/1978847146662134104) [@biospace](/creator/x/biospace) 2025-10-16T15:34Z 25.4K followers, XXX engagements "After a chaotic year that has seen the attrition of over half the FDAs senior leadership many of these individuals have landed new rolesat Eli Lilly Pfizer Iovance and more. The FDAs loss it seems is largely the pharmaceutical industrys gain. #FDA #leadership #pharma #biospace" [X Link](https://x.com/biospace/status/1980277067900960838) [@biospace](/creator/x/biospace) 2025-10-20T14:16Z 25.4K followers, XXX engagements "Novo Nordisks leadership gets another shake-up as President Trump promises to significantly slash prices for its GLP-1 drugs; Summit/Akeso Exelixis and more present new data at ESMO 2025; Replimune pops as FDA accepts resubmitted BLA; FDA names first winners of Commissioners National Priority Voucher program; and more. #podcast #GLP1 #FDA #vouchers #biospace" [X Link](https://x.com/biospace/status/1981002852781674979) [@biospace](/creator/x/biospace) 2025-10-22T14:21Z 25.4K followers, XXX engagements "The discontinued CAR T therapy bbT369 came to Regeneron when the pharma bought all of 2seventy bios pipeline assets for $X million upfront in January 2024. #CART #pharma #biospace" [X Link](https://x.com/biospace/status/1981728633594015784) [@biospace](/creator/x/biospace) 2025-10-24T14:24Z 25.4K followers, XXX engagements "Of the XX companies receiving tax incentives in Massachusetts XX will add jobs outside of Boston and Cambridge. Medtronic which is receiving the largest award will create XXX roles in Billerica. Other recipients include @abbvie @Dyne_tx and @Viridianthera. #nowhiring #biopharma #biospace" [X Link](https://x.com/biospace/status/1981747761247662237) [@biospace](/creator/x/biospace) 2025-10-24T15:41Z 25.4K followers, XXX engagements "The cornerstone of the deal is Ixo-vec an intravitreal gene therapy currently in Phase III development for wet age-related macular degeneration. Eli Lilly made another foray into genetic medicine in June picking up Verve Therapeutics for up to $XXX billion. #genetherapy #pharma #biospace" [X Link](https://x.com/biospace/status/1981755056136282464) [@biospace](/creator/x/biospace) 2025-10-24T16:09Z 25.4K followers, XXX engagements "The deal announced early Sunday afternoon will see Novartis gain access to Aviditys neuroscience assets while the San Diego biotech spins out a new company to shepherd its early-stage precision cardiology programs. #pharma #acquisition #biotech #breakingnews #biospace" [X Link](https://x.com/biospace/status/1982799806536851750) [@biospace](/creator/x/biospace) 2025-10-27T13:21Z 25.4K followers, XXX engagements "The takeover of its competitor announced Sunday could also bring some attention to Dyne Therapeutics which has a similar RNA-based pipeline in rare muscle diseases. #rarediseases #RNA #biospace" [X Link](https://x.com/biospace/status/1982832155135771070) [@biospace](/creator/x/biospace) 2025-10-27T15:29Z 25.4K followers, XXX engagements "Intellia earlier this year reported a similar grade X liver enzyme elevation associated with the gene therapy nexiguran ziclumeran though analysts at BMO Capital Markets at the time brushed it off as a non-concern. #rarediseases #genetherapy #pharma #biospace" [X Link](https://x.com/biospace/status/1982842012488393118) [@biospace](/creator/x/biospace) 2025-10-27T16:09Z 25.4K followers, XXX engagements "Phase III data for dapirolizumab pegol presented at the 2025 conference of the American College of Rheumatology showed quality-of-life benefits in systemic lupus erythematosus that could see Biogen go head-to-head with GSK and AstraZeneca in a blockbuster space. #pharma #biospace" [X Link](https://x.com/biospace/status/1983175919167476066) [@biospace](/creator/x/biospace) 2025-10-28T14:15Z 25.4K followers, XXX engagements "Vas Narasimhan confirmed that Novartis is having weekly discussions with the Trump administration on drug pricing but a deal has not yet been reached. #drugpricing #pharma #biospace" [X Link](https://x.com/biospace/status/1983212824038891715) [@biospace](/creator/x/biospace) 2025-10-28T16:42Z 25.4K followers, XXX engagements "Mergers and acquisitions are not just for Big Pharma. A new report from Leerink Partners takes a stab at identifying the small- to mid-cap pharmas best prepared to bolster their pipelines with a buyout. #pharma #bigpharma #biospace" [X Link](https://x.com/biospace/status/1983521688655380975) [@biospace](/creator/x/biospace) 2025-10-29T13:09Z 25.4K followers, XXX engagements "This represents Alectors second failed neurodegenerative asset in a year after an AbbVie-partnered asset missed in Alzheimers last November. On latozinemab for frontotemporal dementia Alector was working with GSK which fronted $XXX million in 2021 to collaborate on two programs. #dementia #alzheimers #biospace" [X Link](https://x.com/biospace/status/1981029274212610200) [@biospace](/creator/x/biospace) 2025-10-22T16:05Z 25.4K followers, XXX engagements "As third-quarter earnings continue to roll out Novartis makes headlines with the second biggest acquisition of the year; Novartis CEO also downplayed the impact of Big Pharma pricing deals with the Trump administration; Regeneron continued the trend of dropping cell therapy assets; BioSpace takes a look at how the FDA is functioning mid-shutdown. #podcast #celltherapy #FDA #biospace" [X Link](https://x.com/biospace/status/1983538810097951171) [@biospace](/creator/x/biospace) 2025-10-29T14:17Z 25.4K followers, XXX engagements "Eli Lilly and Johnson & Johnson are joining fellow Big Pharma peers in upping their investment in AI with Lilly looking to create the industrys most powerful supercomputer and J&J building a virtual operating room. #AI #bigpharma #biospace" [X Link](https://x.com/biospace/status/1983544348949041452) [@biospace](/creator/x/biospace) 2025-10-29T14:39Z 25.4K followers, XXX engagements "Shingrix sales in the U.S. took a XX% dive in the third quarter. GSK is now the second Big Pharma to report declining vaccine sales after Sanofi reported a similar decline last week. #vaccines #bigpharma #biospace" [X Link](https://x.com/biospace/status/1983581340193653023) [@biospace](/creator/x/biospace) 2025-10-29T17:06Z 25.4K followers, XXX engagements "Late-breaking Phase III data show ianalumab Novartis dual-targeted antibody reduced disease activity and patient burden in Sjgrens disease the pharma reported at the American College of Rheumatology Convergence congress on Wednesday. #pharma #biospace" [X Link](https://x.com/biospace/status/1983596188449259636) [@biospace](/creator/x/biospace) 2025-10-29T18:05Z 25.4K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@biospace
"Despite the rejection analysts saw Regenerons use of an alternate filler for Eylea HD as a positive development with BMO Capital Markets noting that this could signal the end of manufacturing troubles for the franchise. #FDA #manufacturing #pharma #biospace"
X Link @biospace 2025-10-29T15:30Z 25.4K followers, XXX engagements
"Pfizer Merck AstraZeneca and Bristol Myers Squibb were among the many biopharmas showing off novel cancer modalities at ESMO with antibody-drug conjugates bispecific antibodies and kinase inhibitors demonstrating encouraging efficacy and safety for various cancers. #ADC #biopharma #biospace"
X Link @biospace 2025-10-22T18:09Z 25.4K followers, XXX engagements
"From a small team of researchers and skipped salaries CEO Michelle Xia has steered Akeso to become one of the most exciting companies in the industry today. #biotech #biospace"
X Link @biospace 2025-09-17T14:29Z 25.4K followers, XXX engagements
"M&A headlined for a second straight week as Genmab acquired Merus for $X billion; Pfizer strikes most-favored-nation deal with White House; CDER Director George Tidmarsh caused a stir with a now-deleted LinkedIn post; GSK CEO Emma Walmsley will step down from her role; and uniQures gene therapy offers new hope for patients with Huntingtons disease. #podcast #CDER #rarediseases #mergers #biospace"
X Link @biospace 2025-10-01T15:06Z 25.4K followers, XXX engagements
"While the benefits of AI are clear the amount data sets needed for effective AI integration is proving to be a challenge. This is particularly true for cell therapy companies as they are eagerly seeking ways to reduce development costs. Two experts at Charles River Laboratories provide insights by giving their takeaways from their own AI integrations. #AI #CART #celltherapy #biospace"
X Link @biospace 2025-10-13T14:05Z 25.4K followers, XXX engagements
"Regeneron is aiming to file a regulatory application for DB-OTO by the end of the year. #genetherapy #regulatory #biospace"
X Link @biospace 2025-10-13T18:07Z 25.4K followers, XXX engagements
"Elecsys approval could help boost the uptake of currently approved Alzheimers disease therapies including Biogens Eisai-partnered Leqembi with CEO Chris Viehbacher recently noting that such biomarker-based tests could remove some of the bottlenecks in uptake. #alzheimers #FDA #biospace"
X Link @biospace 2025-10-14T15:30Z 25.4K followers, XXX engagements
"After the FDA revoked Sarepta Therapeutics platform designation in July Krystal Biotech is poised to be the first major beneficiary of this program according to analysts at William Blair. #FDA #genetherapy #biotech #biospace"
X Link @biospace 2025-10-15T15:10Z 25.4K followers, XXX engagements
"Due largely to @CSL @Merck and @novonordisks reorganizations that could total about 19350 people Q3 cuts rose significantly year over year and quarter over quarter based on BioSpace tallies. #layoffs #biopharma #biospace"
X Link @biospace 2025-10-16T15:04Z 25.4K followers, XXX engagements
"As part of its restructuring that includes cutting about 9000 employees globally @novonordisk is reportedly laying off U.S. employees this week and continuing into next week. Learn more in our layoff tracker. #layoffs #biopharma #biospace"
X Link @biospace 2025-10-16T15:34Z 25.4K followers, XXX engagements
"After a chaotic year that has seen the attrition of over half the FDAs senior leadership many of these individuals have landed new rolesat Eli Lilly Pfizer Iovance and more. The FDAs loss it seems is largely the pharmaceutical industrys gain. #FDA #leadership #pharma #biospace"
X Link @biospace 2025-10-20T14:16Z 25.4K followers, XXX engagements
"Novo Nordisks leadership gets another shake-up as President Trump promises to significantly slash prices for its GLP-1 drugs; Summit/Akeso Exelixis and more present new data at ESMO 2025; Replimune pops as FDA accepts resubmitted BLA; FDA names first winners of Commissioners National Priority Voucher program; and more. #podcast #GLP1 #FDA #vouchers #biospace"
X Link @biospace 2025-10-22T14:21Z 25.4K followers, XXX engagements
"The discontinued CAR T therapy bbT369 came to Regeneron when the pharma bought all of 2seventy bios pipeline assets for $X million upfront in January 2024. #CART #pharma #biospace"
X Link @biospace 2025-10-24T14:24Z 25.4K followers, XXX engagements
"Of the XX companies receiving tax incentives in Massachusetts XX will add jobs outside of Boston and Cambridge. Medtronic which is receiving the largest award will create XXX roles in Billerica. Other recipients include @abbvie @Dyne_tx and @Viridianthera. #nowhiring #biopharma #biospace"
X Link @biospace 2025-10-24T15:41Z 25.4K followers, XXX engagements
"The cornerstone of the deal is Ixo-vec an intravitreal gene therapy currently in Phase III development for wet age-related macular degeneration. Eli Lilly made another foray into genetic medicine in June picking up Verve Therapeutics for up to $XXX billion. #genetherapy #pharma #biospace"
X Link @biospace 2025-10-24T16:09Z 25.4K followers, XXX engagements
"The deal announced early Sunday afternoon will see Novartis gain access to Aviditys neuroscience assets while the San Diego biotech spins out a new company to shepherd its early-stage precision cardiology programs. #pharma #acquisition #biotech #breakingnews #biospace"
X Link @biospace 2025-10-27T13:21Z 25.4K followers, XXX engagements
"The takeover of its competitor announced Sunday could also bring some attention to Dyne Therapeutics which has a similar RNA-based pipeline in rare muscle diseases. #rarediseases #RNA #biospace"
X Link @biospace 2025-10-27T15:29Z 25.4K followers, XXX engagements
"Intellia earlier this year reported a similar grade X liver enzyme elevation associated with the gene therapy nexiguran ziclumeran though analysts at BMO Capital Markets at the time brushed it off as a non-concern. #rarediseases #genetherapy #pharma #biospace"
X Link @biospace 2025-10-27T16:09Z 25.4K followers, XXX engagements
"Phase III data for dapirolizumab pegol presented at the 2025 conference of the American College of Rheumatology showed quality-of-life benefits in systemic lupus erythematosus that could see Biogen go head-to-head with GSK and AstraZeneca in a blockbuster space. #pharma #biospace"
X Link @biospace 2025-10-28T14:15Z 25.4K followers, XXX engagements
"Vas Narasimhan confirmed that Novartis is having weekly discussions with the Trump administration on drug pricing but a deal has not yet been reached. #drugpricing #pharma #biospace"
X Link @biospace 2025-10-28T16:42Z 25.4K followers, XXX engagements
"Mergers and acquisitions are not just for Big Pharma. A new report from Leerink Partners takes a stab at identifying the small- to mid-cap pharmas best prepared to bolster their pipelines with a buyout. #pharma #bigpharma #biospace"
X Link @biospace 2025-10-29T13:09Z 25.4K followers, XXX engagements
"This represents Alectors second failed neurodegenerative asset in a year after an AbbVie-partnered asset missed in Alzheimers last November. On latozinemab for frontotemporal dementia Alector was working with GSK which fronted $XXX million in 2021 to collaborate on two programs. #dementia #alzheimers #biospace"
X Link @biospace 2025-10-22T16:05Z 25.4K followers, XXX engagements
"As third-quarter earnings continue to roll out Novartis makes headlines with the second biggest acquisition of the year; Novartis CEO also downplayed the impact of Big Pharma pricing deals with the Trump administration; Regeneron continued the trend of dropping cell therapy assets; BioSpace takes a look at how the FDA is functioning mid-shutdown. #podcast #celltherapy #FDA #biospace"
X Link @biospace 2025-10-29T14:17Z 25.4K followers, XXX engagements
"Eli Lilly and Johnson & Johnson are joining fellow Big Pharma peers in upping their investment in AI with Lilly looking to create the industrys most powerful supercomputer and J&J building a virtual operating room. #AI #bigpharma #biospace"
X Link @biospace 2025-10-29T14:39Z 25.4K followers, XXX engagements
"Shingrix sales in the U.S. took a XX% dive in the third quarter. GSK is now the second Big Pharma to report declining vaccine sales after Sanofi reported a similar decline last week. #vaccines #bigpharma #biospace"
X Link @biospace 2025-10-29T17:06Z 25.4K followers, XXX engagements
"Late-breaking Phase III data show ianalumab Novartis dual-targeted antibody reduced disease activity and patient burden in Sjgrens disease the pharma reported at the American College of Rheumatology Convergence congress on Wednesday. #pharma #biospace"
X Link @biospace 2025-10-29T18:05Z 25.4K followers, XXX engagements
/creator/twitter::21793154/posts